Kilitch Drugs to divest Ethiopian arm for $14 million
Kilitch Drugs (India) will divest its entire shareholding in Ethiopian subsidiary, Kilitch Estro Biotech PLC (KEB), to HarmeeCare Pharmaceuticals, an Ethiopian state-owned enterprise, in a transaction valued at $14 million. The transaction forms part of its broader strategy to optimise business portfolio, strengthen financial flexibility and accelerate investments in its pharmaceutical manufacturing operations in India….
Read More “Kilitch Drugs to divest Ethiopian arm for $14 million” »